Recruiting PHASE2 INTERVENTIONAL 2-arm NCT06454669

Dronabinol as an Adjunct for Reducing Pain (DARP)

A Randomized, Double-Blind, Placebo-Controlled, Parallel Groups Study to Explore the Safety and Therapeutic Potential of Dronabinol as an Adjunct for Reducing Pain

Sponsor: Christopher D. Verrico

Conditions Back Injuries Chronic Pain Low Back Pain

Interventions Dronabinol Placebo

Updated 4 times since 2024 Last updated: Mar 11, 2026 Started: Jun 15, 2024 Primary completion: Dec 31, 2028 Completion: Dec 31, 2029

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Back Injuries and Chronic Pain, this trial is actively recruiting participants. The trial is conducted by Christopher D. Verrico and has accumulated 4 data snapshots since 2024. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

4 versions recorded

Mar 2026 — Present [monthly]

Recruiting PHASE2
Mar 2025 — Mar 2026 [monthly]

Recruiting PHASE2
Sep 2024 — Mar 2025 [monthly]

Recruiting PHASE2
Jul 2024 — Sep 2024 [monthly]

Recruiting PHASE2

First recorded

Jun 2024

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Christopher D. Verrico

Data source: Baylor College of Medicine

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Houston, United States